The need for cost-effective choices to treat patients with bipolar 1 disorders including asenapine

Godman, Brian (2015) The need for cost-effective choices to treat patients with bipolar 1 disorders including asenapine. Journal of Medical Economics, 18 (11). pp. 871-873. ISSN 1369-6998

[thumbnail of Godman-JME-2015-The-need-for-cost-effective-choices-to-treat-patients-with-bipolar-1-disorders]
Preview
 Text (Godman-JME-2015-The-need-for-cost-effective-choices-to-treat-patients-with-bipolar-1-disorders)
Godman_JME_2015_The_need_for_cost_effective_choices_to_treat_patients_with_bipolar_1_disorders.pdf
Accepted Author Manuscript
Download (264kB)| Preview

    Abstract

    Bipolar 1 disorders (BPD) are a chronic disorder with prevalence rates up to 2.6% of the adult population or higher and appreciable direct and indirect costs. As a result, a concern to health authorities especially given the low age of onset. Consequently, a need to treat BPD patients well and improve their quality of life. Pharmacotherapy includes mood stabilisers and atypical antipsychotics (AAPs). AAPs have different mechanisms of action and side-effects so treatment needs to be tailored. Asenapine in clinical trials is as effective as olanzapine with less metabolic side-effects. Chitnis and colleagues have shown in routine care that asenapine also reduces hospital and emergency room admissions making it cost neutral in BPD, which is of interest to health authorities and clinicians.

    • Item type:Article
      ID code:53874
      Dates:
      Date
      Event
      2 November 2015
      Published
      26 August 2015
      Published Online
      8 July 2015
      Accepted
      Notes:This is an Accepted Manuscript of an article published by Taylor & Francis in Journal of Medical Economics on 26 August 2015, available online: http://wwww.tandfonline.com/10.3111/13696998.2015.1073736.
      Keywords:bipolar 1 disorders, pharmacotherapy, asenapine, Pharmacy and materia medica, Pharmacology, Toxicology and Pharmaceutics(all)
      Subjects:Medicine > Pharmacy and materia medica
      Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
      Depositing user: Pure Administrator
      Date deposited:27 Jul 2015 10:31
      Last modified:04 May 2021 00:38
      Related URLs:
      URI:https://strathprints.strath.ac.uk/id/eprint/53874
    CORE (COnnecting REpositories)